

.@EMA_News has given a positive opinion on an adapted #COVID19 booster vaccine by BioNTech-Pfizer targeting the BA.4/BA.5 Omicron sub-variants.
— Stella Kyriakides (@SKyriakidesEU) September 12, 2022
It is another key step in supporting Member States’ autumn/winter vaccination efforts.
➡️@EU_Commission authorisation will follow. https://t.co/Tq2EmWsKGb